Zobrazeno 1 - 10
of 56
pro vyhledávání: '"C J Kovacs"'
Publikováno v:
IEEE Transactions on Applied Superconductivity. 33:1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4095b14372dd82cbb4504064c9909076
https://doi.org/10.1109/tasc.2023.3264201
https://doi.org/10.1109/tasc.2023.3264201
Publikováno v:
IOP Conference Series: Materials Science and Engineering. 1241:012019
In the push to develop high power electric aircraft, superconducting technology promises to significantly reduce mass and volume of motors and generators. However, challenges related to AC-loss and thermal management are a significant factor in preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49e96cf5c4b53de4ecd2776e17086ac7
https://doi.org/10.1088/1757-899x/1241/1/012019
https://doi.org/10.1088/1757-899x/1241/1/012019
Publikováno v:
Anticancer research. 25(4)
Earlier, we reported that the local exposure of femoral bone marrow to a clinically-relevant course of fractionated radiotherapy [FxRT; 2.0 Gy (q24h x 5) --74 Gy] resulted in the delayed appearance of a stromal lesion which temporally appeared after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::54aa7a037aa5f57e89d46e3c924b53bb
https://pubmed.ncbi.nlm.nih.gov/16089011
https://pubmed.ncbi.nlm.nih.gov/16089011
Autor:
K P, Kearse, N L, Smith, D A, Semer, L, Eagles, J L, Finley, S, Kazmierczak, C J, Kovacs, A A, Rodriguez, A E, Kellogg-Wennerberg
Publikováno v:
International journal of cancer. 88(6)
A newly developed murine monoclonal antibody, DS6, immunohistochemically reacts with an antigen, CA6, that is expressed by human serous ovarian carcinomas but not by normal ovarian surface epithelium or mesothelium. CA6 has a limited distribution in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3fa7fcf75b268f73af191beab52d9fac
https://pubmed.ncbi.nlm.nih.gov/11093807
https://pubmed.ncbi.nlm.nih.gov/11093807
Publikováno v:
Anticancer research. 18(3A)
Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) interact synergistically to enhance the restoration of stem and progenitor subpopulations in murine marrow and, vis-a-vis, to accelerate hematopoietic recovery in 5FU myelosu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d09f236c940a5f8e0f1a434e074ee590
https://pubmed.ncbi.nlm.nih.gov/9673408
https://pubmed.ncbi.nlm.nih.gov/9673408
Publikováno v:
Anticancer research. 17(3C)
To determine whether non-hematologic tumors influence the bone marrow's antioxidant enzyme response to the radioprotective cytokine interleukin 1 alpha (IL-1), studies were undertaken using BDF1 and Balb/c mice bearing small, medium or large Lewis lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2db734a5326f06a3f0527f17dfcdf567
https://pubmed.ncbi.nlm.nih.gov/9216682
https://pubmed.ncbi.nlm.nih.gov/9216682
Publikováno v:
Experimental hematology. 23(9)
Studies were carried out to establish the temporal effects of abbreviated administrations of IL-1 and IL-1 plus M-CSF as rescue agents on multipotential and short-term repopulating hematopoietic stem cell (HSC) subpopulations in murine marrow treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::092cf15d5f9af7087c225d91b579737b
https://pubmed.ncbi.nlm.nih.gov/7635181
https://pubmed.ncbi.nlm.nih.gov/7635181
Publikováno v:
Experimental hematology. 20(5)
The ability of highly purified, recombinant human macrophage colony-stimulating factor (M-CSF) and recombinant human interleukin 1 alpha (IL-1) to rescue hematopoietic activity from the myelosuppressive effects of 5-fluorouracil (5-FU) was investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1daccd0f440644d460c1d4db8deeb952
https://pubmed.ncbi.nlm.nih.gov/1587305
https://pubmed.ncbi.nlm.nih.gov/1587305
Publikováno v:
Anticancer research. 11(2)
Experiments were designed to establish whether the response of the Lewis lung tumor (LLca) to combined 5-Fluorouracil (5-FU) and radiation could be enhanced by the addition of the reduced folate leucovorin (LV) to the treatment protocol. Twenty-four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8e21a05cbc116468474b2a6f82ab5f8
https://pubmed.ncbi.nlm.nih.gov/2064349
https://pubmed.ncbi.nlm.nih.gov/2064349